The Six-Month Visit Note Is Quietly Denying Your CGM Claims

Coverage got wider. Documentation didn't get easier.

For years, a Medicare patient had to be on intensive insulin therapy — roughly three or more injections a day, or an insulin pump — to qualify for a continuous glucose monitor. That rule kept the covered population small and the paperwork relatively predictable.

Then, effective April 16, 2023, CMS threw the doors open. Now any insulin-treated patient can qualify, and so can patients who aren't on insulin at all if they have a documented history of problematic hypoglycemia. Overnight, the pool of eligible beneficiaries jumped, and CGM orders started flowing into DME intake desks that had been handling a trickle.

Here's the part that catches suppliers off guard. Wider eligibility didn't loosen the documentation standard. It raised the stakes on it. A patient who clearly qualifies on paper still generates a denied claim if the file doesn't prove the qualifying visit happened, the insulin or hypoglycemia history is written down, and the order carries the right elements. The device is covered. The claim is not — because coverage and documentation are two different tests, and only one of them is your problem to solve.

What a CGM claim actually has to prove

Under the Glucose Monitor policy that governs these claims, a beneficiary qualifies for a therapeutic CGM when a short list of conditions all hold at once. Stripped of the legal phrasing, they come down to this:

The patient has diabetes. The patient is treated with insulin, or has a history of problematic hypoglycemia documented as either more than one level 2 event (glucose under 54 mg/dL) or at least one level 3 event that required someone else to step in. Within the six months before the order, the treating practitioner saw the patient in person — or over an approved telehealth visit — evaluated their diabetes management, and decided the CGM was warranted. And after that, every six months, there's another visit on file confirming the patient is actually using the device and it's still doing its job.

None of that is exotic. The trouble is that most of it happens in the ordering physician's office, weeks before the referral ever reaches you. By the time the order lands on an intake desk, the note that proves the visit occurred is a document your team has to go ask for — and often doesn't, because the order looks complete on its face.

The CGM order tells you what the doctor wants. It rarely tells you whether the visit that has to sit behind it actually exists in the chart.

The three moments a CGM claim can die

CGM denials don't cluster at one point. They happen at three distinct handoffs, and each one has its own missing document:

The first denial is a one-time hit. The second and third repeat — every quarter, on every patient — which is what makes CGM such a quiet drain. A single supplier running a few hundred active CGM patients can lose the same $300 supply claim over and over because a follow-up visit note never made it into the file, and nobody flagged it until the remittance came back.

The documents most likely to sink the claim

Not every CGM gap carries the same weight. These are the ones that show up again and again on denied glucose-monitor claims, ranked by how often they turn into lost revenue.

Look at that top row again. The gaps that hurt most aren't sloppy data entry — they're documents that never lived in your building. Your intake coordinator can validate every field on the order and still ship a claim that dies, because the note that has to sit behind the order is in a clinic across town. That's not a coordinator problem. It's a workflow that ends at the order instead of following it back to the chart.

What intake should check before a CGM ships

This isn't the full coverage policy. It's the practical pass your team can run on every glucose-monitor file before it goes into the submission queue — the handful of checks that catch the denials above.

The problem is the moment, not the people

Ask any DME billing lead about their CGM denials and you'll hear the same thing: the coordinators are sharp, they know the coverage rules, and they're already stretched. The follow-up visit note doesn't get pulled because pulling it means chasing a document in someone else's system, in the middle of an intake queue that doesn't pause for it.

So the check that should happen before the claim goes out happens after the denial comes back. And with CGM, that after-the-fact scramble repeats every ninety days, on every patient, because the continued-need requirement never stops asking the same question.

A CGM patient can be perfectly eligible for years and still generate a denied claim every quarter — all because one recurring visit note keeps falling out of the file.

The fix isn't more effort at intake. It's moving the visit-note check upstream and making it automatic, so the file can't move to resupply without the document that keeps the claim payable. Catch it before submission and it costs nothing. Catch it on the remittance and you're appealing a claim that was never going to pay.

What to do this week

Whatever tooling you have, three moves are worth making now:

1. Pull your CGM denials from the last 90 days and sort them

Separate the initial-order denials from the resupply denials. If the resupply column is bigger, your leak is the six-month follow-up note — and that's a repeating loss you can quantify per patient, per quarter.

2. Tie your resupply trigger to a current visit note

If your resupply process fires on a calendar date without checking whether a follow-up visit is on file, you're shipping claims that are already at risk. The trigger should ask for the note before it releases the order.

3. Find where a human first reads the whole CGM file

In a lot of operations, the first complete review of a glucose-monitor file happens at billing — after the equipment is out the door. Knowing exactly where that review sits today is the starting point for moving it to intake, where a missing note costs a phone call instead of a claim.

CGM volume isn't slowing down. The coverage expansion made sure of that. The only question is whether the documentation leaving your intake desk can survive the same visit-note test the payer runs every single time.